News & Events

StageBio Announces David Bruning as New CEO & President

StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President. Bringing over 25 years of leadership experience in a multitude of roles, including five years serving on the StageBio Board of Directors, Mr. Bruning's industry knowledge positions him to guide StageBio to a successful future.

Read the full press release here.

For additional questions, contact our team. StageBio is a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research.

Back to Index

Upcoming Events

SOT

Date: March 10-14
Location: Salt Lake City, Utah
Stop by our booth #717 and attend our sessions:

  • Immunotoxicity II Poster Session,
    March 12 from 11:45am - 1:45pm
  • Informational Session:
    “Through the Lens: Translational Insights in Ocular Toxicology” on Wednesday, March 13, 2024 from 11:00am–12:20pm

Popular Posts

Learn more about StageBio’s COVID-19 response